WPC
ARNA

Waters Parkerson & Co’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Waters Parkerson & Co’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,680
Closed -$206K – 179
2020
Q4 		$206K Buy
+2,680
New +$201K 0.01% 166
2017
Q2 		– Sell
-2,858
Closed -$42K – 171
2017
Q1 		$42K Hold
2,858
– – ﹤0.01% 169
2016
Q4 		$41K Hold
2,858
– – ﹤0.01% 168
2016
Q3 		$50K Buy
+2,858
New +$47.4K 0.01% 160

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Waters Parkerson & Co's ARNA Position: Q1 2021 in Review

Waters Parkerson & Co sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2021, closing a stake of 2,680 shares — an estimated $206K sold.

Waters Parkerson & Co first reported a position in ARNA in Q3 2016 and held it in 4 quarters. The position peaked at $206K in Q4 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q1 2021.

  • Waters Parkerson & Co reported no remaining Arena Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
  • Waters Parkerson & Co sold 2,680 Arena Pharmaceuticals Inc shares in Q1 2021, an estimated $206K.
  • Waters Parkerson & Co first reported a position in Arena Pharmaceuticals Inc in Q3 2016 and held it in 4 quarters.
  • Waters Parkerson & Co's Arena Pharmaceuticals Inc position peaked at $206K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2021.

Based on Waters Parkerson & Co's 13F filing for Q1 2021, filed 12 May 2021.